These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6372660)

  • 1. Cellular action of calcium channel blocking drugs.
    Schwartz A; Triggle DJ
    Annu Rev Med; 1984; 35():325-39. PubMed ID: 6372660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists.
    Nayler WG
    Eur Heart J; 1980 Jun; 1(3):225-37. PubMed ID: 7285980
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists. Pharmacodynamic effects and mechanism of action.
    Zsotér TT; Church JG
    Drugs; 1983 Feb; 25(2):93-112. PubMed ID: 6131809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies.
    Godfraind T; Salomone S; Dessy C; Verhelst B; Dion R; Schoevaerts JC
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S34-41. PubMed ID: 1282611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca(2+)-channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamil.
    Gendron FP; Latour JG; Gravel D; Wang Y; Beaudoin AR
    Biochem Pharmacol; 2000 Dec; 60(12):1959-65. PubMed ID: 11108813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists.
    Conti CR; Pepine CJ; Feldman RL; Hill JA
    Cardiology; 1985; 72(5-6):297-321. PubMed ID: 2866840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of calcium antagonists on sympathetic nerve activity.
    Zsotér TT; Wolchinsky C
    Can J Cardiol; 1986; 2(4):256-60. PubMed ID: 3768782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical differentiation of nifedipine and other calcium antagonists.
    Ebner F; Donath M; Rämsch KD
    Arq Bras Cardiol; 1984 Jul; 43(1):5-12. PubMed ID: 6395839
    [No Abstract]   [Full Text] [Related]  

  • 12. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.
    Hof RP
    Br J Pharmacol; 1983 Feb; 78(2):375-94. PubMed ID: 6831117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic effect of calcium slow channel blockers (verapamil, nifedipine and diltiazem) in ventricular arrhythmias induced by coronary artery occlusion in dogs.
    Kaur AH; Singh M; Singh J
    Indian J Exp Biol; 1986 May; 24(5):287-91. PubMed ID: 3770817
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-type calcium channel antagonism - Translation from in vitro to in vivo.
    Fermini B; Ramirez DS; Sun S; Bassyouni A; Hemkens M; Wisialowski T; Jenkinson S
    J Pharmacol Toxicol Methods; 2017; 84():86-92. PubMed ID: 27856310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.
    Vinge E; Andersson TL; Larsson B
    Acta Physiol Scand; 1988 Jul; 133(3):407-16. PubMed ID: 2906509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.